DISPARITIES IN STAGE-APPROPRIATE THERAPY FOR RESECTABLE NON-SMALL CELL LUNG CANCER IN KENTUCKY
Lung cancer (NSCLC) is the leading cause of cancer related mortality. Lung cancer screening aims to detect treatable cancers, however survival advantage will only be seen with early and appropriate stage-directed therapy. This study aims to understand recent rates of therapy for early-stage lung can...
Main Author: | Martin, Jeremiah T. |
---|---|
Format: | Others |
Published: |
UKnowledge
2017
|
Subjects: | |
Online Access: | http://uknowledge.uky.edu/crd_etds/1 http://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1000&context=crd_etds |
Similar Items
-
The Association between Marital Status and Extensive Stage Small-cell Lung Cancer at Diagnosis in Kentucky Residents, 2005-2009
by: Blackley, David, et al.
Published: (2013) -
Rheumatology in East Asia
by: Kazuhiko Yamamoto, et al.
Published: (2018-03-01) -
Resection of Early-Stage Second Primary Non-small Cell Lung Cancer After Small Cell Lung Cancer: A Population-Based Study
by: Rusi Zhang, et al.
Published: (2020-02-01) -
Neutrophil-lymphocyte ratio predicts recurrence in patients with resected stage 1 non-small cell lung cancer
by: Shinjiro Mizuguchi, et al.
Published: (2018-06-01) -
Comparison Of Long Term Results Between Matched Chemoradiotherapy And Surgery For Limited Stage Small Cell Lung Cancer
by: Chen M, et al.
Published: (2019-10-01)